|Day Low/High||10.83 / 11.43|
|52 Wk Low/High||6.36 / 16.81|
GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced the presentation of further data from the pivotal phase III FULFIL study with investigational closed triple combination therapy fluticasone...
GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced that the results from the pioneering Salford Lung Study (SLS) have been published in the New England Journal of Medicine (NEJM).
Innoviva, Inc. (NASDAQ:INVA) today announced that Michael W.
Board members who sit on four or more boards may find it impossible to manage their time when faced with an insurgent investor or merger situation -- or both.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Innoviva Inc , where a total volume of 15,003 contracts has been traded thus far today, a contract volume which is representative of approximately 1.5 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 216.2% of INVA's average daily trading volume over the past month, of 693,865 shares.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCC, CYS, DISH, ESRT, FCFS, FSI, GIMO, INVA, KSU, NATI, ORC, RMCF, TREE, WLDN, WMGI, WRE, ZION Downgrades: ACIW, ACOR, BSX, DLR, FI, HTH, IP, OVBC, SBBX Initiations: GNRT, MB, PUB Read on to get TheStreet Quant Ratings' detailed report:
Innoviva, Inc. (NASDAQ:INVA) today reported financial results for the second quarter ended June 30, 2016.
Trade-Ideas LLC identified Innoviva (INVA) as a strong on high relative volume candidate
Innoviva, Inc. (NASDAQ:INVA) announced today that it will report financial results for the second quarter ended June 30, 2016 after market close on Thursday July 28, 2016.
Trade-Ideas LLC identified Innoviva (INVA) as a weak on high relative volume candidate
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Trade-Ideas LLC identified Innoviva (INVA) as a "dead cat bounce" (down big yesterday but up big today) candidate
Investors in Innoviva Inc saw new options begin trading this week, for the September 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 228 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.